Results 51 to 60 of about 378,426 (279)
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin +12 more
wiley +1 more source
A Computational Model of the LGI1 Protein Suggests a Common Binding Site for ADAM Proteins [PDF]
Mutations of human leucine-rich glioma inactivated (LGI1) gene encoding the epitempin protein cause autosomal dominant temporal lateral epilepsy (ADTLE), a rare familial partial epileptic syndrome.
Leonardi, Emanuela +23 more
core +1 more source
Molecular characterization of covRS mutations in M1UK Streptococcus pyogenes
Group A Streptococcus (GAS) acquires covRS mutations driving a hypervirulent bacterial state, frequently associated with invasive disease‐like necrotizing fasciitis. We demonstrate that the newly emerged M1UK GAS lineage can also acquire these mutations.
Jarrad Pritchard +12 more
wiley +1 more source
The aim of this study was to investigate the effects of 6-week beta-hydroxy-beta methylbutyrate-free acid (HMB-FA) supplementation on oxidative stress and biochemical variables in responses to resistance training. Sixteen healthy young males participated
Hamid Arazi +2 more
doaj +1 more source
Synthesis and spectroscopic studies of new leucine acid derivative with their metal complexes. [PDF]
A new ligand N-[(acetyl amino)-thioxo methyl]leucine(ATL) are synthesized by reaction of acetyl-isothio cyanate with leucine acid. The ligand is characterized by elemental analysis, FT-IR and NMR spectra, some transition metal complex of this ligand were
Muhammed Ahmed.Awaad +2 more
doaj +1 more source
EFFICIENT LEUCINE TRANSPORT ACROSS THE PLACENTAL BARRIER DEPENDS ON PHYSIOLOGICAL, OPPOSITELY DIRECTED LEUCINE GRADIENTS [PDF]
Objectives: We aimed to assess the concentrations and importance of physiological amino acid (AA) gradients between the maternal and fetal compartments to determine the transport activity of leucine using a 3D in vitro model with trophoblast cells ...
Moser-Hässig, Ruedi +4 more
core
The C‐terminal domain of yeast Arginyltransferase1 is essential for its catalytic activity
Arginyltransferase 1 (Ate1), a eukaryotic enzyme, catalyses arginylation, transferring arginine from tRNA‐Arg to the amino terminus of the target protein. Overexpression of Ate1 in yeast is lethal and is dependent on arginylation. This study elucidates how mutations in the cofactor‐binding and active site of Ate1 and truncation of its structural ...
Vikas Kumar Yadav +4 more
wiley +1 more source
The impact of continuous renal replacement therapy for metabolic disorders in infants
Background: While Continuous Renal Replacement Therapy (CRRT) is a well established treatment modality for patients with acute kidney insufficiency (AKI), it is now also being used for the management of various illnesses such as acute metabolic disorders
Fatih Aygun +5 more
doaj +1 more source
The catalytic subunit of the system L1 amino acid transporter (Slc7a5) facilitates nutrient signalling in mouse skeletal muscle [PDF]
The System L1-type amino acid transporter mediates transport of large neutral amino acids (LNAA) in many mammalian cell-types. LNAA such as leucine are required for full activation of the mTOR-S6K signalling pathway promoting protein synthesis and cell ...
Adel F M Ibrahim +31 more
core +1 more source
Human ABCE1 cannot functionally replace its yeast ortholog. Yeast–human chimera analysis identified NBD1 as a major interspecies barrier. Genetic screening yielded hABCE1 revertants that rescue yeast viability but fail to suppress aberrant translation reinitiation in the 3′ UTR.
Eriko Nakata +3 more
wiley +1 more source

